These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33753261)

  • 1. The development of highly potent and selective small molecule correctors of Z α
    Liddle J; Pearce AC; Arico-Muendel C; Belyanskaya S; Brewster A; Brown M; Chung CW; Denis A; Dodic N; Dossang A; Eddershaw P; Klimaszewska D; Haq I; Holmes DS; Jagger A; Jakhria T; Jigorel E; Lind K; Messer J; Neu M; Olszewski A; Ronzoni R; Rowedder J; Rüdiger M; Skinner S; Smith KJ; Trottet L; Uings I; Zhu Z; Irving JA; Lomas DA
    Bioorg Med Chem Lett; 2021 Jun; 41():127973. PubMed ID: 33753261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a small molecule that corrects misfolding and increases secretion of Z α
    Lomas DA; Irving JA; Arico-Muendel C; Belyanskaya S; Brewster A; Brown M; Chung CW; Dave H; Denis A; Dodic N; Dossang A; Eddershaw P; Klimaszewska D; Haq I; Holmes DS; Hutchinson JP; Jagger AM; Jakhria T; Jigorel E; Liddle J; Lind K; Marciniak SJ; Messer J; Neu M; Olszewski A; Ordonez A; Ronzoni R; Rowedder J; Rüdiger M; Skinner S; Smith KJ; Terry R; Trottet L; Uings I; Wilson S; Zhu Z; Pearce AC
    EMBO Mol Med; 2021 Mar; 13(3):e13167. PubMed ID: 33512066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency.
    Yip E; Giousoh A; Fung C; Wilding B; Prakash MD; Williams C; Verkade H; Bryson-Richardson RJ; Bird PI
    Biol Chem; 2019 Nov; 400(12):1603-1616. PubMed ID: 31091192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retarded protein folding of the human Z-type α₁-antitrypsin variant is suppressed by Cpr2p.
    Jung CH; Kim YH; Lee K; Im H
    Biochem Biophys Res Commun; 2014 Feb; 445(1):191-5. PubMed ID: 24502947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design.
    Gooptu B; Miranda E; Nobeli I; Mallya M; Purkiss A; Brown SC; Summers C; Phillips RL; Lomas DA; Barrett TE
    J Mol Biol; 2009 Apr; 387(4):857-68. PubMed ID: 19232354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective advantage of alpha1-antitrypsin deficiency.
    Lomas DA
    Am J Respir Crit Care Med; 2006 May; 173(10):1072-7. PubMed ID: 16439713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-chain variable fragment intrabody prevents intracellular polymerization of Z α1-antitrypsin while allowing its antiproteinase activity.
    Ordóñez A; Pérez J; Tan L; Dickens JA; Motamedi-Shad N; Irving JA; Haq I; Ekeowa U; Marciniak SJ; Miranda E; Lomas DA
    FASEB J; 2015 Jun; 29(6):2667-78. PubMed ID: 25757566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of G Signaling 16 is a marker for the distinct endoplasmic reticulum stress state associated with aggregated mutant alpha1-antitrypsin Z in the classical form of alpha1-antitrypsin deficiency.
    Hidvegi T; Mirnics K; Hale P; Ewing M; Beckett C; Perlmutter DH
    J Biol Chem; 2007 Sep; 282(38):27769-80. PubMed ID: 17635928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular species responsible for α
    Ronzoni R; Heyer-Chauhan N; Fra A; Pearce AC; Rüdiger M; Miranda E; Irving JA; Lomas DA
    FEBS J; 2021 Apr; 288(7):2222-2237. PubMed ID: 33058391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein.
    Teckman JH; Perlmutter DH
    J Biol Chem; 1996 May; 271(22):13215-20. PubMed ID: 8662752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution ex vivo NMR spectroscopy of human Z α
    Jagger AM; Waudby CA; Irving JA; Christodoulou J; Lomas DA
    Nat Commun; 2020 Dec; 11(1):6371. PubMed ID: 33311470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of endoplasmic reticulum chaperone complexes, redox state, and impaired protein disulfide reductase activity in misfolding alpha1-antitrypsin transgenic mice.
    Papp E; Száraz P; Korcsmáros T; Csermely P
    FASEB J; 2006 May; 20(7):1018-20. PubMed ID: 16571774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of misfolding and conformational change in α1-antitrypsin deficiency.
    Nyon MP; Gooptu B
    Future Med Chem; 2014 Jun; 6(9):1047-65. PubMed ID: 25068987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum.
    Perlmutter DH
    Methods Mol Biol; 2003; 232():39-56. PubMed ID: 12840538
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequestration of mutated alpha1-antitrypsin into inclusion bodies is a cell-protective mechanism to maintain endoplasmic reticulum function.
    Granell S; Baldini G; Mohammad S; Nicolin V; Narducci P; Storrie B; Baldini G
    Mol Biol Cell; 2008 Feb; 19(2):572-86. PubMed ID: 18045994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody.
    Tan L; Perez J; Mela M; Miranda E; Burling KA; Rouhani FN; DeMeo DL; Haq I; Irving JA; Ordóñez A; Dickens JA; Brantly M; Marciniak SJ; Alexander GJ; Gooptu B; Lomas DA
    Int J Biochem Cell Biol; 2015 Jan; 58():81-91. PubMed ID: 25462157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency.
    Lawless MW; Greene CM; Mulgrew A; Taggart CC; O'Neill SJ; McElvaney NG
    J Immunol; 2004 May; 172(9):5722-6. PubMed ID: 15100318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-α1-antitrypsin.
    Dickens JA; Ordóñez A; Chambers JE; Beckett AJ; Patel V; Malzer E; Dominicus CS; Bradley J; Peden AA; Prior IA; Lomas DA; Marciniak SJ
    FASEB J; 2016 Dec; 30(12):4083-4097. PubMed ID: 27601439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic mechanism for the polymerization of alpha1-antitrypsin.
    Dafforn TR; Mahadeva R; Elliott PR; Sivasothy P; Lomas DA
    J Biol Chem; 1999 Apr; 274(14):9548-55. PubMed ID: 10092640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on alpha-1 antitrypsin deficiency: New therapies.
    Lomas DA; Hurst JR; Gooptu B
    J Hepatol; 2016 Aug; 65(2):413-24. PubMed ID: 27034252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.